• Epidemiology, screening and prevention
  • Clinical staging in multimodality treatment
  • Biomarkers in clinical staging
  • Clinical impact of different histotypes
  • High technology in gastric cancer diagnosis and treatment
  • Treatment of early forms
  • Treatment of clinical stage I/II
  • Locally-advanced gastric cancer
  • Treatment of patients “unfit” for multimodal approach
  • Post-operative management
  • Oligometastatic gastric cancer
  • Bidirectional treatments, conversion surgery
  • Esophagogastric junction – early stages
  • Esophagogastric junction – advanced stages
  • Molecular phenotype and clinical behaviour
  • Targeted therapies, immunotherapy and their combination with multimodal approach
  • Prediction of outcome and recurrence
  • Nutritional support, pre-habilitation, palliative therapies